Evidence map›Paper›PMID 20195479›Full record

ArticlePloS one2010

A tyrosine residue on the TSH receptor stabilizes multimer formation.

Rauf Latif, Krzysztof Michalek, Syed Ahmed Morshed, Terry F Davies

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Graves' disease.Nature reviews. Disease primers · 2020
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rauf LatifThyroid Research Unit, James J. Peters VA Medical Center, Mount Sinai School of Medicine, New York, New York, United States of America. rauf.latif@mssm.edu
Krzysztof Michalek
Syed Ahmed Morshed
Terry F Davies
Icahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · US

Funding

Small Molecules and Antibodies Interacting at the TSH ReceptorR01DK069713 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAVIES, TERRY FRANCIS · 2006 to 2019
$5.6M
SUSCEPTIBILITY GENES IN AUTOIMMUNE THYROID DISEASER01DK052464 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DAVIES, TERRY FRANCIS · 1997 to 2013
$3.0M
NIDDK NIH HHS DK052464NIDDK NIH HHS DK069713NIDDK NIH HHS R01 DK052464NIDDK NIH HHS R01 DK069713
6 · The paper itself

Abstract

backgroundThe thyrotropin stimulating hormone receptor (TSHR) is a G protein coupled receptor (GPCR) with a large ectodomain. The ligand, TSH, acting via this receptor regulates thyroid growth and thyroid hormone production and secretion. The TSH receptor (TSHR) undergoes complex post-translational modifications including intramolecular cleavage and receptor multimerization. Since monomeric and multimeric receptors coexist in cells, understanding the functional role of just the TSHR multimers is difficult. Therefore, to help understand the physiological significance of receptor multimerization, it will be necessary to abrogate multimer formation, which requires identifying the ectodomain and endodomain interaction sites on the TSHR. Here, we have examined the contribution of the ectodomain to constitutive multimerization of the TSHR and determined the possible residue(s) that may be involved in this interaction. METHODOLOGY/PRINCIPAL

findingsWe studied ectodomain multimer formation by expressing the extracellular domain of the TSHR linked to a glycophosphotidyl (GPI) anchor in both stable and transient expression systems. Using co-immunoprecipitation and FRET of tagged receptors, we established that the TSH receptor ectodomain was capable of multimerization even when totally devoid of the transmembrane domain. Further, we studied the effect of two residues that likely made critical contact points in this interaction. We showed that a conserved tyrosine residue (Y116) on the convex surface of the LRR3 was a critical residue in ectodomain multimer formation since mutation of this residue to serine totally abrogated ectodomain multimers. This abrogation was not seen with the mutation of cysteine 176 on the inner side of the LRR5, demonstrating that inter-receptor disulfide bonding was not involved in ectodomain multimer formation. Additionally, the Y116 mutation in the intact wild type receptor enhanced receptor degradation. CONCLUSIONS/SIGNIFICANCE: These data establish the TSH receptor ectodomain as one site of multimerization, independent of the transmembrane region, and that this interaction was primarily via a conserved tyrosine residue in LRR3.

Indexed as

Protein MultimerizationProtein Structure, TertiaryAnimalsBinding SitesCell LineCHO CellsCricetinaeCricetulusCyclic AMPFluorescence Resonance Energy TransferHumansModels, MolecularMutationProtein BindingReceptors, ThyrotropinTransfectionCyclic AMPReceptors, ThyrotropinTyrosine

Identifiers

PMID20195479
PMCPMC2829087
OpenAlexW2041295128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.